Substance active (DCI)
- nifédipine
- lidocaïne chlorhydrate
Informations techniques
Exploitant
LABORATOIRES LEURQUIN MEDIOLANUM SAS
Présentation
NIFEXINE,0,3 g/1,50 g, crème rectale
1 tube(s) aluminium de 30 g avec canule endorectale en polyéthylène basse densité (PEBD) (CIP : 34009 302 010 1 5)
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
L48DABDAgVmt2brD
Écouter
Français